- CFO Spotlights
- Profiles
- Robert W. McMahon
Profile
Robert W. McMahon
Senior Vice President, Chief Financial Officer (Principal Financial Officer), West Pharmaceutical Services
In the seat. First published here October 28, 2026; built from records as of October 28, 2026.
Robert W. McMahon signed the annual report of West Pharmaceutical Services as Senior Vice President, Chief Financial Officer (Principal Financial Officer); the report was filed on February 17, 2026, the most recent filing in the record that ties Robert W. McMahon to the seat.1
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| West Pharmaceutical Services (WST) Surgical & Medical Instruments & Apparatus | Senior Vice President, Chief Financial Officer (Principal Financial Officer) | In the seat |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- February 17, 202610-K filed
Robert W. McMahon signed the annual report of West Pharmaceutical Services on Form 10-K as Senior Vice President, Chief Financial Officer (Principal Financial Officer), filed February 17, 2026.
/s/ Robert W. McMahon Senior Vice President, Chief Financial Officer February 17, 2026 Robert W. McMahon (Principal Financial Officer)
[1] Annual report on Form 10-K by West Pharmaceutical Services, filed with the SEC on February 17, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Annual report on Form 10-K, West Pharmaceutical Services. U.S. Securities and Exchange Commission, EDGAR, filed February 17, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Robert W. McMahon wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.